These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
441 related items for PubMed ID: 19615866
1. Efflux pump inhibitors reduce the invasiveness of Pseudomonas aeruginosa. Hirakata Y, Kondo A, Hoshino K, Yano H, Arai K, Hirotani A, Kunishima H, Yamamoto N, Hatta M, Kitagawa M, Kohno S, Kaku M. Int J Antimicrob Agents; 2009 Oct; 34(4):343-6. PubMed ID: 19615866 [Abstract] [Full Text] [Related]
2. An efflux pump (MexAB-OprM) of Pseudomonas aeruginosa is associated with antibacterial activity of Epigallocatechin-3-gallate (EGCG). Kanagaratnam R, Sheikh R, Alharbi F, Kwon DH. Phytomedicine; 2017 Dec 01; 36():194-200. PubMed ID: 29157815 [Abstract] [Full Text] [Related]
3. MexAB-OprM- and MexXY-overproducing mutants are very prevalent among clinical strains of Pseudomonas aeruginosa with reduced susceptibility to ticarcillin. Hocquet D, Roussel-Delvallez M, Cavallo JD, Plésiat P. Antimicrob Agents Chemother; 2007 Apr 01; 51(4):1582-3. PubMed ID: 17220417 [No Abstract] [Full Text] [Related]
4. Multidrug efflux systems play an important role in the invasiveness of Pseudomonas aeruginosa. Hirakata Y, Srikumar R, Poole K, Gotoh N, Suematsu T, Kohno S, Kamihira S, Hancock RE, Speert DP. J Exp Med; 2002 Jul 01; 196(1):109-18. PubMed ID: 12093875 [Abstract] [Full Text] [Related]
5. MexAB-OprM hyperexpression in NalC-type multidrug-resistant Pseudomonas aeruginosa: identification and characterization of the nalC gene encoding a repressor of PA3720-PA3719. Cao L, Srikumar R, Poole K. Mol Microbiol; 2004 Sep 01; 53(5):1423-36. PubMed ID: 15387820 [Abstract] [Full Text] [Related]
6. MexAB-OprM specific efflux pump inhibitors in Pseudomonas aeruginosa. Part 7: highly soluble and in vivo active quaternary ammonium analogue D13-9001, a potential preclinical candidate. Yoshida K, Nakayama K, Ohtsuka M, Kuru N, Yokomizo Y, Sakamoto A, Takemura M, Hoshino K, Kanda H, Nitanai H, Namba K, Yoshida K, Imamura Y, Zhang JZ, Lee VJ, Watkins WJ. Bioorg Med Chem; 2007 Nov 15; 15(22):7087-97. PubMed ID: 17869116 [Abstract] [Full Text] [Related]
7. Overexpression of MexAB-OprM efflux pump in carbapenem-resistant Pseudomonas aeruginosa. Pan YP, Xu YH, Wang ZX, Fang YP, Shen JL. Arch Microbiol; 2016 Aug 15; 198(6):565-71. PubMed ID: 27060003 [Abstract] [Full Text] [Related]
8. Resistance against antimicrobial peptides is independent of Escherichia coli AcrAB, Pseudomonas aeruginosa MexAB and Staphylococcus aureus NorA efflux pumps. Rieg S, Huth A, Kalbacher H, Kern WV. Int J Antimicrob Agents; 2009 Feb 15; 33(2):174-6. PubMed ID: 18945595 [Abstract] [Full Text] [Related]
9. Bacteriostatic and bactericidal activities of eight fluoroquinolones against MexAB-OprM-overproducing clinical strains of Pseudomonas aeruginosa. Dupont P, Hocquet D, Jeannot K, Chavanet P, Plésiat P. J Antimicrob Chemother; 2005 Apr 15; 55(4):518-22. PubMed ID: 15722391 [Abstract] [Full Text] [Related]
10. Increased susceptibility of Pseudomonas aeruginosa to macrolides and ketolides in eukaryotic cell culture media and biological fluids due to decreased expression of oprM and increased outer-membrane permeability. Buyck JM, Plésiat P, Traore H, Vanderbist F, Tulkens PM, Van Bambeke F. Clin Infect Dis; 2012 Aug 15; 55(4):534-42. PubMed ID: 22573850 [Abstract] [Full Text] [Related]
11. Multiple genotypic changes in hypersusceptible strains of Pseudomonas aeruginosa isolated from cystic fibrosis patients do not always correlate with the phenotype. Wolter DJ, Black JA, Lister PD, Hanson ND. J Antimicrob Chemother; 2009 Aug 15; 64(2):294-300. PubMed ID: 19468029 [Abstract] [Full Text] [Related]
12. Relationship between antibiotic use and incidence of MexXY-OprM overproducers among clinical isolates of Pseudomonas aeruginosa. Hocquet D, Muller A, Blanc K, Plésiat P, Talon D, Monnet DL, Bertrand X. Antimicrob Agents Chemother; 2008 Mar 15; 52(3):1173-5. PubMed ID: 18180356 [Abstract] [Full Text] [Related]
13. Activity of the efflux pump inhibitor phenylalanine-arginine β-naphthylamide against the AdeFGH pump of Acinetobacter baumannii. Cortez-Cordova J, Kumar A. Int J Antimicrob Agents; 2011 May 15; 37(5):420-4. PubMed ID: 21377839 [Abstract] [Full Text] [Related]
14. Transcriptional Analysis of MexAB-OprM Efflux Pumps System of Pseudomonas aeruginosa and Its Role in Carbapenem Resistance in a Tertiary Referral Hospital in India. Choudhury D, Das Talukdar A, Dutta Choudhury M, Maurya AP, Paul D, Dhar Chanda D, Chakravorty A, Bhattacharjee A. PLoS One; 2015 May 15; 10(7):e0133842. PubMed ID: 26221722 [Abstract] [Full Text] [Related]
15. [The roles of active efflux system overexpression and outer membrane protein OprD deficiency or loss in carbapenem resistance of Pseudomonas aeruginosa]. Yi MY, Wang PY, Huang HJ, Liu YC. Zhonghua Yi Xue Za Zhi; 2006 Feb 21; 86(7):457-62. PubMed ID: 16677571 [Abstract] [Full Text] [Related]
16. Expression of efflux pump MexAB-OprM and OprD of Pseudomonas aeruginosa strains isolated from clinical samples using qRT-PCR. Arabestani MR, Rajabpour M, Yousefi Mashouf R, Alikhani MY, Mousavi SM. Arch Iran Med; 2015 Feb 21; 18(2):102-8. PubMed ID: 25644798 [Abstract] [Full Text] [Related]
17. Tolerance to the antimicrobial peptide colistin in Pseudomonas aeruginosa biofilms is linked to metabolically active cells, and depends on the pmr and mexAB-oprM genes. Pamp SJ, Gjermansen M, Johansen HK, Tolker-Nielsen T. Mol Microbiol; 2008 Apr 21; 68(1):223-40. PubMed ID: 18312276 [Abstract] [Full Text] [Related]
18. Pseudomonas aeruginosa reveals high intrinsic resistance to penem antibiotics: penem resistance mechanisms and their interplay. Okamoto K, Gotoh N, Nishino T. Antimicrob Agents Chemother; 2001 Jul 21; 45(7):1964-71. PubMed ID: 11408209 [Abstract] [Full Text] [Related]
19. A Novel indole compound that inhibits Pseudomonas aeruginosa growth by targeting MreB is a substrate for MexAB-OprM. Robertson GT, Doyle TB, Du Q, Duncan L, Mdluli KE, Lynch AS. J Bacteriol; 2007 Oct 21; 189(19):6870-81. PubMed ID: 17644596 [Abstract] [Full Text] [Related]
20. MexXY-OprM efflux pump is required for antagonism of aminoglycosides by divalent cations in Pseudomonas aeruginosa. Mao W, Warren MS, Lee A, Mistry A, Lomovskaya O. Antimicrob Agents Chemother; 2001 Jul 21; 45(7):2001-7. PubMed ID: 11408215 [Abstract] [Full Text] [Related] Page: [Next] [New Search]